CROI 2024 Program Guide

Poster Sessions

Preclinical Characterization of GS-5894, a Potent NNRTI With Once-Weekly Oral Dosing Potential Eric Lansdon , Andrew Mulato, Petr Jansa, Gary Lee, George Stepan, Mike Matles, Kelly Wang, Carmen Ip, Julie Fogarty, Dan Soohoo, Bernard Murray, Stephen Yant, Zlatko Janeba, Richard L Mackman, Tomas Cihlar Discovery of GS-9770: A Novel Unboosted Once Daily Oral HIV Protease Inhibitor Xiaochun Han , Ron Aoyama, Jacob Cha, Aesop Cho, Ana Z Gonzalez, Salman Jabri, Michael Lee, Albert C Liclican, Ryan McFadden, Andrew Mulato, Zach E Newby, Jie Xu, Johannes Voigt, Lianhong Xu, Hong Yang Discovery of MK-8527: A Long-Acting HIV-1 Nucleoside Reverse Transcriptase Translocation Inhibitor Izzat Raheem, Kerry Fillgrove, Gregory O’Donnell, Jonathan Patteson, Shih Lin Goh, Carolyn Bahnck-Teets, Qian Huang, Ernest Asante Appiah, Min Xu, Steve S Carroll, Jay A Grobler, Jeffrey Hale, Ming-Tain Lai, Vinay Girijavallabhan, Tracy L. Diamond High-Dose VH3810109 (N6LS) ± Recombinant Human Hyaluronidase PH20: Phase I SPAN Study Safety Results Beta Win, Peter Leone , Jan Losos, Paul Wannamaker, Riccardo D’Agostino, Michael Warwick-Sanders, Gabriela L Ghita, Viviana Wilches, Max Lataillade A Dose Escalation Study of Safety & PK of TMB-365 & TMB-380 in People With Suppressed HIV Jacob P Lalezari, Moti Ramgopal, Gary Richmond, Gordon Crofoot, Kuei-Ling Kuo, Yingan Lai, Martin Markowitz Poster Session-G5 | New Formulations of Current Integrase Strand Transfer Inhibitors: Length Matters 2:30 PM - 4:00 PM • Poster Hall C-D Preclinical Pharmacokinetics of a Novel Long-Acting Bictegravir Solid Injectable in Rats Usman Arshad , Joanne Sharp, Megan Neary, Joanne Herriott, Edyta Kijak, Eduardo Gallardo-Toledo, Paul Curley, Helen Cox, Eleanor Barlow, James J Hobson, Andrew B Dwyer, Jonathan Massam, Steve Rannard, Andrew Owen Shape-Shifting Tail Decay Is the Pharmacokinetic Profile of an Ultra-Long Acting Bictegravir Prodrug Mohammad Ullah Nayan , Ivana Massud, Srijanee Das, Brady Sillman, Brandon Hanson, Arpan Acharya, Tiancheng Edwards, Richard Haaland, Siddappa N Byrareddy, Gerardo Garcia-Lerma, Walid Heneine, Charles W Dobard, Howard E Gendelman, Benson Edagwa WITHDRAWN

636

637

638

639

640

Poster Sessions • Wednesday

653

654

655

Cabotegravir Stearate (XVIR-110), an InSTI Prodrug, Provides Ultra-Long Acting Cabotegravir Exposure Brian P. Kearney , Brady Sillman, Howard E Gendelman, Benson Edagwa, Leigh Ann Burns-Naas, Alborz Yazdi

656

CROI 2024 158

New Investigator Scholarship

LB

NIS

Late-Breaking